Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00462852
Status:
COMPLETED
Last Update Posted:
2013-08-12
First Post:
2007-04-18
Brief Title:
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Sponsor:
Hull University Teaching Hospitals NHS Trust
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
PRH-HCTU-FRAGEM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None